Advanced Cancer Therapeutics - Product Pipeline Review - 2014


#228915

26pages

Global Markets Direct

$ 1500

In Stock

Advanced Cancer Therapeutics - Product Pipeline Review - 2014

Summary

Global Markets Directs, Advanced Cancer Therapeutics - Product Pipeline Review - 2014, provides an overview of the Advanced Cancer Therapeuticss pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Cancer Therapeuticss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Advanced Cancer Therapeutics including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Advanced Cancer Therapeuticss human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Advanced Cancer Therapeuticss pipeline products

Reasons to buy

- Evaluate Advanced Cancer Therapeuticss strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Advanced Cancer Therapeutics in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Advanced Cancer Therapeuticss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Advanced Cancer Therapeutics and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advanced Cancer Therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Advanced Cancer Therapeutics and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Advanced Cancer Therapeutics Snapshot 4
Advanced Cancer Therapeutics Overview 4
Key Information 4
Key Facts 4
Advanced Cancer Therapeutics - Research and Development Overview 5
Key Therapeutic Areas 5
Advanced Cancer Therapeutics - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Advanced Cancer Therapeutics - Pipeline Products Glance 9
Advanced Cancer Therapeutics - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Advanced Cancer Therapeutics - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Advanced Cancer Therapeutics - Drug Profiles 12
ACTGRO-777 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
PFK-158 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CK-37 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PFK-015 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PU-27 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Advanced Cancer Therapeutics - Pipeline Analysis 18
Advanced Cancer Therapeutics - Pipeline Products by Target 18
Advanced Cancer Therapeutics - Pipeline Products by Route of Administration 19
Advanced Cancer Therapeutics - Pipeline Products by Molecule Type 20
Advanced Cancer Therapeutics - Pipeline Products by Mechanism of Action 21
Advanced Cancer Therapeutics - Recent Pipeline Updates 22
Advanced Cancer Therapeutics - Dormant Projects 23
Advanced Cancer Therapeutics - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables
Advanced Cancer Therapeutics, Key Information 4
Advanced Cancer Therapeutics, Key Facts 4
Advanced Cancer Therapeutics - Pipeline by Indication, 2014 6
Advanced Cancer Therapeutics - Pipeline by Stage of Development, 2014 7
Advanced Cancer Therapeutics - Monotherapy Products in Pipeline, 2014 8
Advanced Cancer Therapeutics - Phase II, 2014 9
Advanced Cancer Therapeutics - Phase I, 2014 10
Advanced Cancer Therapeutics - Preclinical, 2014 11
Advanced Cancer Therapeutics - Pipeline by Target, 2014 18
Advanced Cancer Therapeutics - Pipeline by Route of Administration, 2014 19
Advanced Cancer Therapeutics - Pipeline by Molecule Type, 2014 20
Advanced Cancer Therapeutics - Pipeline Products by Mechanism of Action, 2014 21
Advanced Cancer Therapeutics - Recent Pipeline Updates, 2014 22
Advanced Cancer Therapeutics - Dormant Developmental Projects,2014 23

List of Figures
Advanced Cancer Therapeutics - Pipeline by Top 10 Indication, 2014 6
Advanced Cancer Therapeutics - Pipeline by Stage of Development, 2014 7
Advanced Cancer Therapeutics - Monotherapy Products in Pipeline, 2014 8
Advanced Cancer Therapeutics - Pipeline by Top 10 Target, 2014 18
Advanced Cancer Therapeutics - Pipeline by Top 10 Molecule Type, 2014 20
Advanced Cancer Therapeutics - Pipeline Products by Top 10 Mechanism of Action, 2014 21